大西洋鱼肝脂肪积累的个体差异的遗传和代谢特征
Siri S Horn1, Anna K Sonesson1, Aleksei Krasnov1
1Nofima (Norwegian institute of Food, Fisheries and Aquaculture research), Tromsø, Norway.
Frontiers in genetics
|February 28, 2025
概括
大西洋鱼的肝脏脂肪含量有显著的变化,有可能通过选择性繁殖进行遗传改进. 这项研究探讨了影响养殖鱼肝脏脂肪沉积的遗传和转录基因因素.
科学领域:
- 水产养殖是水产养殖的一种方式.
- 鱼类生物学 鱼类生物学
- 遗传学 是一个遗传学.
背景情况:
- 肝脏中的脂质积累会对肝脏功能产生负面影响.
- 这一问题在哺乳动物中得到了充分的证据,但在大西洋鱼中却得到了较少的探索.
- 了解肝脏脂肪沉积对于养殖鱼健康至关重要.
研究的目的:
- 调查大西洋鱼肝脂肪含量的表型,遗传和转录基因变异.
- 提高对养殖鱼肝脏脂肪沉积的知识.
- 评估基因改进的潜力,以减少肝脏脂肪.
主要方法:
- 在屠宰大小的大西洋鱼中测量肝脂肪含量.
- 估计的遗传性和进行的全基因组关联研究 (GWAS).
- 进行了转录基因分析,将基因表达与肝脏脂肪含量联系起来.
主要成果:
- 观察到肝脏脂肪 (3.6%-18.8%) 的广泛变化,常见的是高水平.
- 肝脂肪的遗传率为0.38,表明有很大的繁殖潜力.
- 基因表达分析确定了与脂质代谢的联系,包括转录因子LXR,SREBP1和ChREBP.
结论:
- 大西洋鱼的肝脂肪变异是相当大的,是遗传的.
- 选择性育种有可能减少肝脏脂肪沉积.
- 基因表达洞察力揭示了复杂的代谢联系与肝脏脂肪含量.
相关概念视频
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...


